Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 58364-97-9 | MDL No. : | MFCD10699178 |
Formula : | C5H6N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PEABOOUFKYJUKN-UHFFFAOYSA-N |
M.W : | 142.11 | Pubchem ID : | 12251617 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 32.47 |
TPSA : | 75.35 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.12 cm/s |
Log Po/w (iLOGP) : | 0.39 |
Log Po/w (XLOGP3) : | 0.07 |
Log Po/w (WLOGP) : | -0.18 |
Log Po/w (MLOGP) : | -0.55 |
Log Po/w (SILICOS-IT) : | -0.71 |
Consensus Log Po/w : | -0.2 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.07 |
Solubility : | 12.1 mg/ml ; 0.0853 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.21 |
Solubility : | 8.84 mg/ml ; 0.0622 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | 0.43 |
Solubility : | 382.0 mg/ml ; 2.69 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | Stage #1: With sodium hydroxide In water at 20℃; for 5 h; Stage #2: With hydrogenchloride In water |
Ester hydrolysisThe resulting above ester (20.00g:0.11 mol) was stirred in water (100ml) adjusted to approx pH13 by the addition of sodium hydroxide pellets. After stirring for a total of 5 hours at room temperature the pH was adjusted to pH 1 by the addition of 2N hydrochloric acid and the precipitate filtered. The resulting solid was stirred with acetone filtered and dried to give an off white solid (9.2Og: 59percent; mass spectrum (M H) -ve 141 ). |
[ 51985-95-6 ]
Methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate
Similarity: 0.92
[ 51986-17-5 ]
Ethyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate
Similarity: 0.90
[ 89603-60-1 ]
5-Hydroxy-1H-pyrazole-3-carboxylic acid
Similarity: 0.89
[ 1018446-60-0 ]
Methyl 5-hydroxy-1H-pyrazole-3-carboxylate
Similarity: 0.82
[ 85230-37-1 ]
Ethyl 5-hydroxy-1H-pyrazole-3-carboxylate
Similarity: 0.79
[ 139297-51-1 ]
5-Methoxy-1-methyl-1H-pyrazole-3-carboxylic acid
Similarity: 0.90
[ 89603-60-1 ]
5-Hydroxy-1H-pyrazole-3-carboxylic acid
Similarity: 0.89
[ 25016-20-0 ]
1-Methyl-1H-pyrazole-3-carboxylic acid
Similarity: 0.84
[ 400755-44-4 ]
1-Ethylpyrazole-3-carboxylic Acid
Similarity: 0.76
[ 51985-95-6 ]
Methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate
Similarity: 0.92
[ 139297-51-1 ]
5-Methoxy-1-methyl-1H-pyrazole-3-carboxylic acid
Similarity: 0.90
[ 51986-17-5 ]
Ethyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate
Similarity: 0.90
[ 89603-60-1 ]
5-Hydroxy-1H-pyrazole-3-carboxylic acid
Similarity: 0.89
[ 58364-91-3 ]
Methyl 5-methoxy-1-methyl-1H-pyrazole-3-carboxylate
Similarity: 0.85